Summit Therapeutics Inc vs Zeta Global Holdings Corp — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Zeta Global Holdings Corp trades at $21.18 (market cap $5.32B). The key difference: Summit Therapeutics Inc is the larger of the two by market cap, and Zeta Global Holdings Corp is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | ZETA | |
|---|---|---|
Market Cap | $10.48B | $5.32B |
Sector | Health | Technology |
52-Week High | $29.32 | $25.24 |
52-Week Low | $13.05 | $14.55 |
Enterprise Value | $9.90B | $5.23B |
Trailing returns across standard periods
Latest headlines on both assets
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Zeta Global is a leading data-driven marketing technology company that provides an omnichannel AI Marketing Cloud. By leveraging a proprietary data cloud of over 2.4 billion deterministic identities, it enables enterprise brands to acquire, grow, and retain customers through predictive intelligence and automated, agentic workflows.
Read more on ZETA →